175 related articles for article (PubMed ID: 38635081)
1. Role of transient receptor potential ankyrin 1 in idiopathic pulmonary fibrosis: modulation of M2 macrophage polarization.
Yang Y; Xiao Z; Yang W; Sun Y; Sui X; Lin X; Yang X; Bao Z; Cui Z; Ma Y; Li W; Wang S; Yang J; Wang Y; Luo Y
Cell Mol Life Sci; 2024 Apr; 81(1):187. PubMed ID: 38635081
[TBL] [Abstract][Full Text] [Related]
2. Icariside II modulates pulmonary fibrosis via PI3K/Akt/β-catenin pathway inhibition of M2 macrophage program.
Deng L; Ouyang B; Tang W; Wang N; Yang F; Shi H; Zhang Z; Yu H; Chen M; Wei Y; Dong J
Phytomedicine; 2024 Jul; 130():155687. PubMed ID: 38759312
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice.
Chen Y; Wang T; Liang F; Han J; Lou Z; Yu Y; Li J; Zhan T; Gu Y; Dong L; Jiang B; Zhang W; Wu M; Lu Y
Theranostics; 2024; 14(7):2794-2815. PubMed ID: 38773984
[No Abstract] [Full Text] [Related]
4. Icariside Ⅱ attenuates bleomycin-induced pulmonary fibrosis by modulating macrophage polarization.
Deng L; Ouyang B; Shi H; Yang F; Li S; Xie C; Du W; Hu L; Wei Y; Dong J
J Ethnopharmacol; 2023 Dec; 317():116810. PubMed ID: 37331450
[TBL] [Abstract][Full Text] [Related]
5. TREM2 Insufficiency Protects against Pulmonary Fibrosis by Inhibiting M2 Macrophage Polarization.
Luo Q; Deng D; Li Y; Shi H; Zhao J; Qian Q; Wang W; Cai J; Yu W; Liu J
Int Immunopharmacol; 2023 May; 118():110070. PubMed ID: 37003186
[TBL] [Abstract][Full Text] [Related]
6. TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1-deficient mice in bleomycin-induced experimental model of scleroderma.
Mäki-Opas I; Hämäläinen M; Moilanen E; Scotece M
Arthritis Res Ther; 2023 Jan; 25(1):12. PubMed ID: 36698198
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus ameliorates bleomycin-induced pulmonary fibrosis by inhibiting M2 macrophage polarization via JAK2/STAT3 signaling.
Liu B; Jiang Q; Chen R; Gao S; Xia Q; Zhu J; Zhang F; Shao C; Liu X; Li X; Zhou H; Yang C; Huang H
Int Immunopharmacol; 2022 Dec; 113(Pt A):109424. PubMed ID: 36461589
[TBL] [Abstract][Full Text] [Related]
8. Schisandra Inhibit Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Rats via Suppressing M2 Macrophage Polarization.
Guo Z; Li S; Zhang N; Kang Q; Zhai H
Biomed Res Int; 2020; 2020():5137349. PubMed ID: 32884941
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of lung TRPV1/TRPA1 in a cough model of bleomycin-induced pulmonary fibrosis in Guinea pigs.
Guo Y; Ying S; Zhao X; Liu J; Wang Y
BMC Pulm Med; 2019 Feb; 19(1):27. PubMed ID: 30717786
[TBL] [Abstract][Full Text] [Related]
10. Localized Administration of Bcar3 siRNA via Nano-Self-Assembly to Treat Idiopathic Pulmonary Fibrosis by Disrupting Macrophage-Fibroblast Crosstalk.
Zeng C; Wang Q; Liu X; Wang K; Wang C; Ju X; Wang T; Zhou Q; Fu X; Yu J; Wang Y
Int J Nanomedicine; 2024; 19():1827-1842. PubMed ID: 38414524
[TBL] [Abstract][Full Text] [Related]
11. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway.
Zhu L; Fu X; Chen X; Han X; Dong P
Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530
[TBL] [Abstract][Full Text] [Related]
12. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
13. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
[TBL] [Abstract][Full Text] [Related]
14. Rac2 is required for alternative macrophage activation and bleomycin induced pulmonary fibrosis; a macrophage autonomous phenotype.
Joshi S; Singh AR; Wong SS; Zulcic M; Jiang M; Pardo A; Selman M; Hagood JS; Durden DL
PLoS One; 2017; 12(8):e0182851. PubMed ID: 28817691
[TBL] [Abstract][Full Text] [Related]
15. Myeloid DNA methyltransferase3b deficiency aggravates pulmonary fibrosis by enhancing profibrotic macrophage activation.
Qin W; Spek CA; Scicluna BP; van der Poll T; Duitman J
Respir Res; 2022 Jun; 23(1):162. PubMed ID: 35725453
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the mechanism of ethyl acetate extract from
Li S; Hu G; Kuang L; Zhou T; Jiang H; Pang F; Li J; Chen X; Bao J; Li W; Li C; Li M; Wang L; Zhang D; Zhang J; Yang Z; Jin H
Front Immunol; 2023; 14():1330055. PubMed ID: 38259493
[TBL] [Abstract][Full Text] [Related]
17. Daikenchuto (Da-Jian-Zhong-Tang) ameliorates intestinal fibrosis by activating myofibroblast transient receptor potential ankyrin 1 channel.
Hiraishi K; Kurahara LH; Sumiyoshi M; Hu YP; Koga K; Onitsuka M; Kojima D; Yue L; Takedatsu H; Jian YW; Inoue R
World J Gastroenterol; 2018 Sep; 24(35):4036-4053. PubMed ID: 30254408
[TBL] [Abstract][Full Text] [Related]
18. Eucalyptol prevents bleomycin-induced pulmonary fibrosis and M2 macrophage polarization.
Rui Y; Han X; Jiang A; Hu J; Li M; Liu B; Qian F; Huang L
Eur J Pharmacol; 2022 Sep; 931():175184. PubMed ID: 35964659
[TBL] [Abstract][Full Text] [Related]
19. Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppression of TGF-β1 production and TGF-β1-induced fibroblast differentiation.
Nie Y; Zhang D; Qian F; Wu Y
Int Immunopharmacol; 2019 Sep; 74():105696. PubMed ID: 31229901
[TBL] [Abstract][Full Text] [Related]
20. Targeting pathogenic macrophages by the application of SHP-1 agonists reduces inflammation and alleviates pulmonary fibrosis.
Hong SY; Lu YT; Chen SY; Hsu CF; Lu YC; Wang CY; Huang KL
Cell Death Dis; 2023 Jun; 14(6):352. PubMed ID: 37291088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
